| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Stephen Mark Cone is Director at BTMD. Stephen Mark Cone's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $188K at current prices.
Net of sales, the BTMD filings show accumulation of 121,454 shares.
Stephen Mark Cone has 12 Form 4 filings on record from May 2022 to May 2026, all as Director at biote (BTMD), 2022–2026.
The 16 reported transactions were 10 option or other derivative awards, 4 option exercises and 2 open-market purchases.
Counted by filing, the open-market trades come to 2 purchases worth about $398K and no sales.
The largest open-market purchase was 83,350 shares of BTMD at an average $3.00 on January 9, 2023, about $250K. Twelve months later BTMD was up 41%.